<code id='80205034C4'></code><style id='80205034C4'></style>
    • <acronym id='80205034C4'></acronym>
      <center id='80205034C4'><center id='80205034C4'><tfoot id='80205034C4'></tfoot></center><abbr id='80205034C4'><dir id='80205034C4'><tfoot id='80205034C4'></tfoot><noframes id='80205034C4'>

    • <optgroup id='80205034C4'><strike id='80205034C4'><sup id='80205034C4'></sup></strike><code id='80205034C4'></code></optgroup>
        1. <b id='80205034C4'><label id='80205034C4'><select id='80205034C4'><dt id='80205034C4'><span id='80205034C4'></span></dt></select></label></b><u id='80205034C4'></u>
          <i id='80205034C4'><strike id='80205034C4'><tt id='80205034C4'><pre id='80205034C4'></pre></tt></strike></i>

          Home / fashion / comprehensive

          comprehensive


          comprehensive

          author:knowledge    Page View:4872
          Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

          In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

          The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks. 

          advertisement

          “Oh, crap,” Secrist said to herself.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In